Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single‐center retrospective study

Abstract Background Sentinel lymph node biopsy (SLNB) helps to determine accurate pathological stages and facilitates strategies for regional disease control in melanoma. However, whether the number of biopsied sentinel lymph nodes (SLNs) influences the patients' survival is rarely investigated...

Full description

Bibliographic Details
Main Authors: Tu Hu, Yu Xu, Wangjun Yan, Chunmeng Wang, Wei Sun, Yunyi Kong, Yong Chen
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.1958
_version_ 1797292565662269440
author Tu Hu
Yu Xu
Wangjun Yan
Chunmeng Wang
Wei Sun
Yunyi Kong
Yong Chen
author_facet Tu Hu
Yu Xu
Wangjun Yan
Chunmeng Wang
Wei Sun
Yunyi Kong
Yong Chen
author_sort Tu Hu
collection DOAJ
description Abstract Background Sentinel lymph node biopsy (SLNB) helps to determine accurate pathological stages and facilitates strategies for regional disease control in melanoma. However, whether the number of biopsied sentinel lymph nodes (SLNs) influences the patients' survival is rarely investigated. Methods Acral or cutaneous melanoma patients with no history of nodal disease who received SLNB in Fudan University Shanghai Cancer Center (FUSCC) from January 1, 2017, to December 31, 2021 were retrospectively enrolled. Clinicopathological variables including Breslow index, ulceration, number of positive SLNs, SLN/non‐SLN status were analyzed. The pathologic nodal (pN) stage and pathological stage were defined. Results A total of 381 eligible patients were enrolled in this study, of whom 132 (34.7%) patients were diagnosed with SLN‐positive. The median number of biopsied SLNs was 2 (range: 1 to 20). Different numbers of biopsied SLNs did not influence the release‐free survival (RFS) of the general patients. However, patients with >2 SLNs had a longer RFS than those with 1–2 SLNs in T4, N1a group and those who rejected complete lymph node dissection (CLND). Conclusions In patients with T4 melanomas, N1a melanomas and those that did not undergo a CLND, the prognosis of those with three or more SLNs retrieved seemed to be improved.
first_indexed 2024-03-07T19:58:18Z
format Article
id doaj.art-a953289ee4d14133b60c672260619fe4
institution Directory Open Access Journal
issn 2573-8348
language English
last_indexed 2024-03-07T19:58:18Z
publishDate 2024-02-01
publisher Wiley
record_format Article
series Cancer Reports
spelling doaj.art-a953289ee4d14133b60c672260619fe42024-02-28T13:54:58ZengWileyCancer Reports2573-83482024-02-0172n/an/a10.1002/cnr2.1958Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single‐center retrospective studyTu Hu0Yu Xu1Wangjun Yan2Chunmeng Wang3Wei Sun4Yunyi Kong5Yong Chen6Department of Musculoskeletal Surgery Fudan University Shanghai Cancer Center Shanghai ChinaDepartment of Musculoskeletal Surgery Fudan University Shanghai Cancer Center Shanghai ChinaDepartment of Musculoskeletal Surgery Fudan University Shanghai Cancer Center Shanghai ChinaDepartment of Musculoskeletal Surgery Fudan University Shanghai Cancer Center Shanghai ChinaDepartment of Musculoskeletal Surgery Fudan University Shanghai Cancer Center Shanghai ChinaDepartment of Pathology Fudan University Shanghai Cancer Center, Fudan University Shanghai ChinaDepartment of Musculoskeletal Surgery Fudan University Shanghai Cancer Center Shanghai ChinaAbstract Background Sentinel lymph node biopsy (SLNB) helps to determine accurate pathological stages and facilitates strategies for regional disease control in melanoma. However, whether the number of biopsied sentinel lymph nodes (SLNs) influences the patients' survival is rarely investigated. Methods Acral or cutaneous melanoma patients with no history of nodal disease who received SLNB in Fudan University Shanghai Cancer Center (FUSCC) from January 1, 2017, to December 31, 2021 were retrospectively enrolled. Clinicopathological variables including Breslow index, ulceration, number of positive SLNs, SLN/non‐SLN status were analyzed. The pathologic nodal (pN) stage and pathological stage were defined. Results A total of 381 eligible patients were enrolled in this study, of whom 132 (34.7%) patients were diagnosed with SLN‐positive. The median number of biopsied SLNs was 2 (range: 1 to 20). Different numbers of biopsied SLNs did not influence the release‐free survival (RFS) of the general patients. However, patients with >2 SLNs had a longer RFS than those with 1–2 SLNs in T4, N1a group and those who rejected complete lymph node dissection (CLND). Conclusions In patients with T4 melanomas, N1a melanomas and those that did not undergo a CLND, the prognosis of those with three or more SLNs retrieved seemed to be improved.https://doi.org/10.1002/cnr2.1958lymph node metastasismelanomaprognosissentinel lymph node biopsy
spellingShingle Tu Hu
Yu Xu
Wangjun Yan
Chunmeng Wang
Wei Sun
Yunyi Kong
Yong Chen
Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single‐center retrospective study
Cancer Reports
lymph node metastasis
melanoma
prognosis
sentinel lymph node biopsy
title Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single‐center retrospective study
title_full Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single‐center retrospective study
title_fullStr Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single‐center retrospective study
title_full_unstemmed Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single‐center retrospective study
title_short Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single‐center retrospective study
title_sort prognostic value of the number of biopsied sentinel lymph nodes for chinese patients with melanoma a single center retrospective study
topic lymph node metastasis
melanoma
prognosis
sentinel lymph node biopsy
url https://doi.org/10.1002/cnr2.1958
work_keys_str_mv AT tuhu prognosticvalueofthenumberofbiopsiedsentinellymphnodesforchinesepatientswithmelanomaasinglecenterretrospectivestudy
AT yuxu prognosticvalueofthenumberofbiopsiedsentinellymphnodesforchinesepatientswithmelanomaasinglecenterretrospectivestudy
AT wangjunyan prognosticvalueofthenumberofbiopsiedsentinellymphnodesforchinesepatientswithmelanomaasinglecenterretrospectivestudy
AT chunmengwang prognosticvalueofthenumberofbiopsiedsentinellymphnodesforchinesepatientswithmelanomaasinglecenterretrospectivestudy
AT weisun prognosticvalueofthenumberofbiopsiedsentinellymphnodesforchinesepatientswithmelanomaasinglecenterretrospectivestudy
AT yunyikong prognosticvalueofthenumberofbiopsiedsentinellymphnodesforchinesepatientswithmelanomaasinglecenterretrospectivestudy
AT yongchen prognosticvalueofthenumberofbiopsiedsentinellymphnodesforchinesepatientswithmelanomaasinglecenterretrospectivestudy